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Surgical Treatment for Chronic Critical Leg Ischaemia: 
a 5 year Follow-up of Socioeconomic Outcome 
M. Luther* 
Vasa Central Hospital, Surgical Department, Vasa, Finland 
Objectives: To evaluate the costs of amputation and arterial reconstruction for chronic critical leg ischaemia (CLI). 
Design: A 5 year follow-up study of patients with primary intervention for CLI. 
Setting: One regional and two district hospitals erving a defined population. 
Material: One hundred and seventeen consecutive patients undergoing reconstructive arterial surgery or amputation 
for CLI. 
Chief outcome measures: Additional procedures, treatment resources and costs related to the treatment of CLL 
Main results: Reconstruction patients needed frequent reinterventions due to graft problems, additional CLI symptoms 
and revisions of ischaemic tissue. The mean costs for a reconstruction were 240 000 FIM/patient and 70 000 FIM/survival 
year including costs for later amputations. Patients with a reconstruction without later amputation had costs of 175 000/ 
patient and 47 O00/survival year. A reconstruction with a later amputation had the highest costs, 402 O00/patient and 
148000~survival year. Contralateral eg ischaemia caused a new intervention in 25% of all patients. For non-in- 
stitutionalised patients an amputation resulted in institutional treatment in over 20% of the remaining surviving days 
with a cost of 313 O00 FIM/patient and 150 O00FIM/survival year. CLI in institutionalised patients with a primary 
amputation had a short stay in hospital, needed little additional resources and caused only low additional costs. 
Conclusions: Costs for a reconstruction in potentially mobile, independently living patients with CLI is similar to those 
of an amputation. It often demands repeated interventions to achieve good results. On a cost~survival year basis, 
amputations carry higher costs. For institutionalised, immobile patients with CLI an amputation is often the only possible 
and cheapest treatment. 
Key Words: Critical leg ischaemia; Reconstruction; Amputation; Treatment level; Costs. 
Introduction 
In society today, cost containment is a goal that extends 
into the health care sectorJ '2 Vascular surgery is ex- 
pensive and graft failures, especially in infrainguinal 
surgery for chronic critical leg ischaemia (CLI), in- 
crease  costs .  2'3 CLI is the most important indication 
for reconstruction in leg ischaemia nd with an ageing 
population the incidence of CLI is increasing. 4'5Prim- 
ary amputation has been proposed as a more economic 
use of scarce resources. 6 However, it has never been 
demonstrated that primary amputation is a cost-effect- 
ive solution to the problem of CLI. 2'4 On the contrary 
there are indications that amputations result in high 
costs for the society by necessitating care over an 
extended time for the amputees that cannot be re- 
habilitated back to walking. 7-9 Especially difficult is 
*Please address all correspondence to: M. Luther, Surgical 
Department, Vasa Central Hospital, Sandviksg. 2-4, 65130 Vasa, 
Finland. 
the rehabilitation of elderly patients. 1°An aggressive 
reconstructive surgery for CL! has also been shown to 
decrease amputation rates in the oldest patient groups 
thereby preserving their mobility and quality of 
lifeY 1-16 
The aim of the present study was to evaluate re- 
source consumption and costs for treating CLI in a 
setting where an aggressive reconstruction policy has 
been pursued for an extended time. 
Material and Methods 
The Vasa region has a population of 170 000 persons 
served by one central and two district hospitals. Vas- 
cular surgery is performed in the central hospital while 
some amputations are done in the district hospitals. 
An aggressive reconstruction policy focused on leg 
salvage in CLI has been pursued since the early 1980s. 
Every patient with CLI where leg loss would sig- 
nificantly limit mobility is offered a reconstruction in 
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Table 1. Demographics of patients reconstructed and amputated for CLI. 
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All 
amputations 
Amputations, Amputations, on- All 
institutionalised institutionalised reconstructions 
patients patients 
Reconstruction Reconstruction 
. only + amputation 
Number 51 27 
Women 32 (63%) 19 (70%) 
Median age 81 years 83 years 
Risk factors 
Diabetes 29 (57%) 13 (48%) 
Cardiovascular 27 (47%) 14 (52%) 
Indication 
Rest pain 2 (4%) 1 (4%) 
Ulcer 9 (18%) 4 (15%) 
Gangrene 40 (78%) 22 (81%) 
Preoperative mobility 
Walking 22 (43%) 7 (26%) 
Wheelchair 11 (22%) 6 (22%) 
In bed 13 (25%) 13 (48%) 
Unknown 5 (10%) 1 (4%) 
Preoperative treatment level 
At home 15 (29%) 
Service housing 2 (4%) 
Social institution 9 (18%) 
Health centre ward 18 (35%) 
Hospital 4 (8%) 
Unknown 2 (4%) 
Median postoperative 16 months 
survival 
9 (33%) 
18 (67%) 
9 months 
24 
13 (54%) 
76 years 
16 (67%) 
13 (54%) 
1 (4%) 
5 (21%) 
18 (75%) 
15 (62%) 
5 (21%) 
4 (17%) 
17 (71%o) 
2 (8°) 
2 
3 
26 
66 47 19 
39 (59%) 26 (55%) 13 (68%) 
75 years 73 years 75 years 
33 (50%) 19 (40%) 14 (74%) 
48 (73%) 37 (79%) 11 (58%) 
29 (44%) 25 (53%) 4 (21%) 
21 (32%) 12 (26%) 9 (47%o) 
16 (24%) 10 (21%) 6 (32%o) 
59 (89%) 43 (92%) 16 (84%) 
5(8%) 2(4%) 3(16%) 
1 (1.5%o) 1 (2%) 
1 (1.5%o) 1 (2%) 
55 (83%) 40 (86%) 15 (79%) 
1 (2%) 1 (2%) 
2(3%) 1(2%) 1(5%) 
2 (3%) 2 (4%) 
(8%) 6(9%) 2(4%) 3(16%) 
(13%) 1 (2%) 1 (2%) 
months 51 months 53 months 31 months 
preference to an amputation. If necessary, recon- 
structions are performed down to the foot arteries. 
This has resulted in a reduction in the frequency of 
amputation by 60%. 5 
One hundred and seventeen consecutive patients 
referred to surgery for their first episode of CLI during 
a 3 year period (1.1.1989 to 31.12.1991) were included 
in the present study (Table 1). Primary amputation 
was performed in 51 patients, 27 of these were in 
institutional care preoperatively while 24 were living 
independently. Twenty amputations were performed 
in the district hospitals, all other procedures were 
performed in the central hospital. 
Primary reconstruction was performed in 66 
patients: nine PTA, 15 surgical reconstructions in the 
aortofemoral region and 42 infrainguinal recon- 
structions. Nineteen patients with reconstructions later 
underwent an amputation, either of the same or contra- 
lateral leg. In all, 86 amputations were performed, 16 
patients had bilateral amputations and 47 patients 
were not amputated. All patients were followed for 5 
years, until death or the end of 1995. 
The main analysis was made comparing primarily 
amputated and reconstructed patients. A subset ana- 
lysis was also performed comparing preoperatively 
institutionalised and non-institutionalised patients in 
the amputation group and patients with and without 
a subsequent amputation i  the reconstruction group. 
Analysis of resource consumption was based on unit 
costs for each procedure or service, applied to the 
actual use of resources on each treatment level. In the 
primary treatment i was based on hospital treatment 
days, use of operation theatre, radiological ex- 
aminations and interventions, and use of the intensive 
care unit. During follow-up, the visits in the outpatient 
department, examinations, and reinterventions were 
included in resource analysis. For care during follow- 
up, the actual times spent at different reatment levels 
were registered for the entire period (Table 2). 
Costs were calculated only as additional costs for 
treatment caused by CLI (Table 3). Costs were included 
Table 2. Treatment levels and their calculated care costs per day. 
1. Home 
Patient lives alone or with relative without support from society. 
2. Home support 181 FIM/day 
Patient needs regular assistance from society with household 
or treatment for 1-3 h/day. 
3. Service housing 192 FIM/day 
Patient lives in apartment with access to assistance in same 
house. F ex daily meals erved. 
4. Social institution 356 F1M/day 
Home for old persons or like, with staff assisting daily with 
basic service. 
5. Health centre ward 550 FIM/day 
Ward with daily nursing care and medical treatment. 
6. District hospital 1313 or 1462 FIM/day 
General surgeon, performs amputations, ot vascular surgery. 
7. Central hospital 1570 FIM/day 
Vascular surgeon, performs reconstructions and amputation. 
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Table 3. Cost components. 
1. Primary treatment 
Hospital ward costs per day (M) 
Radiology: Angiographies + interventional r diology (I) 
Surgery (I) 
Intensive care (M) 
2. Follow-up treatment 
Outpatient visits (including examinations) (I) 
Reinterventions (including contralateral leg procedures) 
Hospital ward costs per day (M) 
Radiology (I) 
Surgery (I) 
Intensive care (M) 
3. Rehabilitation 
Physiotherapy outpatient visits (I) 
Prosthesis/equipment cos s (wheelchair, walkers, crutches) (I
Home alterations for rehabilitation (I) 
Institutional rehabilitation periods (M) 
4. Institutional care (Social institution, Health centre ward) (M) 
5. Home care (Home service, Service housing) (M) 
Cost calculation for (M) was calculated asa mean per unit used by 
each patient, e.g. days at care level and visits in home care. Cost 
calculation for (I) was based on the actual use of resources for each 
patient, e.g. angiographies, operation minutes for each patient, 
vascular prosthesis, acquired rehabilitation equipment, home al- 
teration costs etc. 
irrespective of the payer and calculated according to 
the cost level of 1995. They were calculated for primary 
treatment, follow-up treatment, long-term care at dif- 
ferent levels of institutions and rehabilitation (Table 
2). The basis for calculating postoperative care costs 
for each patient was the preoperative treatment level 
and changes in this. According to this, postoperative 
increases or decreases in long-term care costs were 
calculated. As the charges to patients in the hospitals 
are nominal, covering <5% of surgical inpatient costs 
and about 20% of costs for outpatient visit, costs and 
not charges were used as the basis for calculations. As 
charges for chronic care vary depending on different 
factors, costs and not charges have also been used for 
these calculations. Care costs were calculated using 
expenses per day. At the hospital level the actual 
costs per day in each hospital were used. Ward costs 
included basic care, routine laboratory and non-ex- 
pensive radiological examinations (plain chest X-ray), 
administration and investment costs for buildings and 
their maintenance (Table 3). For the nine health centre 
wards, social institutions, home service and service 
housing a mean per day value was calculated for each 
level. 
For the primary hospital treatment, costs were cal- 
culated for ward stay-days, surgery, intensive care, 
expensive radiological examinations (e.g. angio- 
graphy) and treatments (PTA). Costs for surgery were 
based on the real use of resources in the operation 
theatre using the time spent in the operation room by 
each included patient as the main measurement unit 
with addition of costs for prosthetic material. For 
intensive care the mean costs per day were used. 
The calculation of follow-up costs included radio- 
logical examinations (angiography), new inter- 
ventions, new ward stays, outpatient visits and 
examinations according to the same principles as for 
the primary treatment. Outpatient visit costs in the 
surgical department included duplex Doppler costs 
when this was used in the follow-up of infrainguinal 
reconstructions. Costs for contralateral leg CLI in- 
terventions were calculated separately although it was 
not possible to specify subsequent care costs as be- 
longing to either leg. Rehabilitation costs were cal- 
culated based on the use of the physiotherapy 
department resources, real costs for prosthetics and 
home alterations made for the rehabilitation. Costs for 
institutional care included costs for stay in institutions 
at levels 4-5, while costs for home care included levels 
2-3 (Table 2). 
Comparison of parametric data was performed by 
the Chi-squared test. Comparison of survival days 
and costs patientwise between unpaired samples (two 
groups) was made by Mann-Whitney U-test. Sub- 
group analysis (four groups) was made by the analysis 
of variance (ANOVA). If ANOVA revealed ifferences 
between the groups, Scheffe's test was used to locate 
the significant differences between two groups. To be 
able to compare data in the cost group the logarithm 
of the costs had to be used to achieve a more normal 
data distribution for application of the ANOVA. 
Results 
Additional procedures 
In the reconstruction group reinterventions were fre- 
quent (Table 4). Procedures included vascular re- 
operations, revisions of distal necroses and later 
amputations. In addition to reinterventions on the 
primarily reconstructed leg there were 34 interventions 
on the contralateral leg due to CLI in 29 patients, 17 
of these were primarily reconstructed and 12 primarily 
amputated. The need to perform reinterventions was 
highest for patients with infrainguinal reconstructions 
with a mean of 2.3 new procedures per patient. About 
half of the reinterventions were vascular procedures, 
the rest being amputations, revisions of gangrenous 
toes, ulcers or operation wound complications. In the 
amputation group the reintervention frequency was 
low with a mean of only 0.4 procedures in the AK 
amputation group. A total of 135 vascular procedures, 
86 major amputations and 55 minor procedures were 
performed uring the 5 years. 
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Table 4. Additional procedures and outpatient visits after primary amputation or reconstruction. Proximal vascular reconstructions: 
aorto-ilico-femoral area. Distal vascular reconstructions: reconstructions originating below the inguinal ligament. 
BK AK Proximal vascular Distal vascular PTA 
amputation amputation reconstruction reconstruction 
Primary operations 14 37 15 
Additional procedures within 30 days (vascular/total) 4 6 2/5 
Later additional procedures (vascular*/total) 2/14 2/11 10/14 
Ipsilateral mputations 1 0 0"* 
Contralateral procedures 6 8 1"** 
Contralateral amputations 4 4 0 
Contralateral econstructions 2 1 1 
Outpatient visits 20 0 105 
Physiotherapy visits 58 12 0 
42 9 
12/31 0 
36/65 5/10 
14"* 0 
17'** 4 
8 1 
9 3 
272 46 
49 0 
* Significant difference between later vascular procedures after amputation (BK+AK) and reconstruction (proximal + vascular + PTA) 
p<0.0001. 
** Significant difference between proximal and distal reconstructions p = 0.01. 
*** Significant difference between proximal and distal reconstructions p = 0.016. 
The reconstructed patients had a mean of 6.4 follow- 
up visits in the outpatient clinic while only eight of 
the primarily amputated patients visited the physio- 
therapy department for rehabilitation. Seven of the 19 
secondarily amputated patients also visited physio- 
therapy a mean of seven times for rehabilitation. 
Treatment resources 
The mean primary hospital stay for patients under- 
going a reconstruction was 19 days while it was 32 
days for primary amputation patients. In the subgroup 
of institution patients amputated the mean hospital 
primary stay was only 14 days while it was 53 days 
for the patients living independently prior to the am- 
putation. 
During the 5 year follow-up the reconstruction 
group aggregated 82 599 survival days of which 85% 
was spent living independently, which was sig- 
nificantly more than amputation patients (p<0.001) 
(Fig. 1). The reconstructed patients pent 10% of their 
time in institutional care and 5% in hospital for primary 
reconstruction and for later additional procedures 
which was different from the amputation patients 
(p<0.001). The use of institutional care in the re- 
construction group was mainly caused by later am- 
putations. The 47 patients without later amputation 
spent 92% of their time at home or in service housing, 
4% in institutions and 4% in hospital. The 19 patients 
undergoing a later amputation spent 67% at home or 
in service housing, 24% in institutions and 10% in 
hospital. 
The amputation group accrued 32 675 surviving 
days with 42% at home or in service housing, 52% in 
institutional care and 6% in hospital (Fig. 1). The main 
use of institutional care was in the first years with 
decreasing numbers of days during later follow-up as 
the patients died. During the hospital treatment period 
the amputation patients pent more time in the district 
hospitals than the reconstruction patients (p =0.052). 
They also spent more time in the health centre wards 
(p<0.001) and used more home support (p<0.0001) 
than the reconstruction patients. The subgroup of 27 
preoperatively institutionalised patients pent 8% of 
the time at home or in service housing, 89% in in- 
stitutions and 3% in hospital. The 24 preoperatively 
non-institutionalised patients pent 70% at home or in 
service housing, 22% in institutions and 8% in hospital. 
Costs 
The total cost for the treatment of 117 patients was 
25 067 000 FIM (1 US$ =4.5 FIM). The reconstruction 
group consumed 63% of this amount. The costs in 
the reconstruction group were mainly caused by the 
primary treatment, follow-up with reinterventions and 
institutional care for the patients with later am- 
putations (Table 5). For the primary amputations the 
two main costs were primary treatment and in- 
stitutional care. The reconstruction patients had sig- 
nificantly more primary care (p<0.017) and follow-up 
(p<0.001) costs than the amputation patients, while the 
rehabilitation costs for the amputation patients were 
higher (p<0.001). The mean costs for a reconstruction 
was 240 100FIM, with a subsequent amputation in- 
creasing costs (Table 5). For patients with a subsequent 
amputation the costs for institutional care and home 
care were 4-6 times higher. 
The mean cost for an amputation was 180 800 FIM, 
with higher costs for non-institutionalised patients 
(Table 5). The costs for the institutionalised patients 
was low due to a short stay in hospital, little change 
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Reconstructions 
82 597 days 
Amputations 
32 ~7.q daw 
,Cent ra l  hospital 
[ ]Distr ict  hospital 
[ ]Hea l th  centre 
ward 
[ ]Soc ia l  
institution 
[ ]Serv ice housing 
[ ]Home support 
[ ]Home 
Fig. 1. Distribution of survival days during 5 years after 66 reconstructions and 51 amputations for CLL Difference in institutional care 
(hospitals + health centre ward -- social institution) vs.home care (service housing + home support ÷ home)between reconstructions 
and amputations; p<0.0001 (Mann-Whitney), calculated from accrued individual patient days. 
in care level costs and a short survival. There was 
even a reduction in institutional care costs for some 
patients who could be cared for at a less expensive 
level after amputation. For the non-institutionalised 
patients the cost for each patient was more than six 
times higher than for the institutionalised patients due 
to longer survival, additional costs for long treatments 
in hospital, institutional and home care (Fig. 2). The 
costs for these patients that were demographically 
comparable to the reconstruction patients were similar 
to those for all reconstructions (Fig. 2) and 60% higher 
than for a successful reconstruction (p= 0.033). 
As survival for the patient groups was different, the 
costs per survival year during the 5 year period was 
calculated (Fig. 3). Comparing these, the costs for 
amputated non-institutionalised patients were 3.6 
times that of the institutionalised patients (p =0.01). 
The costs for the amputated non-institutionalised 
patients were 114% higher than for reconstructions 
(p<0.001) and 220% higher than for a successful re- 
construction (p<0.001), similar to the costs for a re- 
construction followed by a later amputation. 
Costs for treatment of contralateral leg CLI were 
calculated separately although they are included in 
the overall costs for follow-up treatment. For the 29 
patients with a contralateral leg intervention for CLI 
the mean cost per patient was 344 700 rIM. For the 16 
patients with a primary reconstruction and a later 
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Table 5. Mean costs (FIM) for amputation and reconstruction subgroups. Numbers in brackets indicate the interquartile range. Negative 
numbers indicate a cost saving in relation to preoperative treatment. 
Amputation Reconstruction 
Institutionalised Non-institutionalised Successful + Amputation 
Primary treatment 25 700 
(10 400-35 000) 
Follow-up treatment 23 300 
(6300-34 00) 
Rehabilitation 4300 
(0-7000) 
Chronic care 
Institutionalised 17 000 
(0-200) 
Home - 10 800 
(0-0) 
Cost/patient 59 300 
(16 600-97100) 
88400 44700 63000 
(21000-155700) (24300-54300) (36700-90000) 
95900 157400 
(12100-159 700) (23 400-121700) (94 300-199 800) 
10 900 62 10 300 
(0-13 600) (0-0) (0-12 500) 
87100 24 000 109 500 
(0-118 00) (0-0) (0-182 600) 
32000 9900 59000 
(0-30 500) (oM)) (0-74 600) 
313300 174800 " 401500 
95200-503100) (55400-239900)  (237600~20500) 
contralateral procedure the mean total cost was 
398 900FIM while the direct cost for treating the 
contralateral CLI was 56 400 FIM/patient.  The 
corresponding cost for patients with a pr imary am- 
putation was 278 000 FIM and 42 400 FIM. Rehab- 
ilitation costs constituted only 2% of the costs of the 
whole group and 4% in the amputat ion group. In the 
group of non-institutionalised patients with pr imary 
1 000 000 
800 000 
600 000 
400 000 
200 000 
-200 000 
-400 000 I I I 
I II III 
(n = 66) (n = 24) (n = 27) 
Fig. 2. Total costs (FIM) for patients undergoing reconstructions (I) 
and independently iving (II) and institutionalised patients (III) 
undergoing primary amputation. Central line indicates median 
values, shaded areas the interquartile range and line end bars the 
range. (C)) indicate outliers and (*) extreme outliers. The difference 
between the institutionalised amputation patients and the other two 
groups is significant (p<0.0001) (Mann-Whitney) while there is no 
significant difference between costs for a reconstruction and an 
amputation of a non-institutionalised patient. 
amputat ion and in those secondarily amputated after 
a reconstruction the costs were 10 000 F IM/pat ient  
while they were smaller (63-4000 FIM/patient) in the 
other groups. 
Discuss ion  
The treatment of CLI is surgically demanding and 
resource consuming. Reconstructions, especially infra- 
inguinal reconstructions that are necessary for a majority 
of patients, frequently need further proceduresY 7 
Pr imary amputat ion is associated with a high mortality 
and the mobil ity and quality of life is reduced for the 
amputated patient. 14-~6'~s For society, either treatment 
is combined with costs that strain budgets J  '2 The treat- 
ment aim is to assure the patient of a clinically optimal 
solution with long-term benefits in an acceptable co- 
nomic frame. With an increasing longevity of the 
populat ion the incidence of CLI is growing, de- 
manding a treatment strategy based on sound clinical 
and socioeconomic arguments. 2'4'~s'19 
The intention of the present study was to discern 
some socioeconomic aspects of treatment. The study 
population included all patients undergoing surgery 
for their first episode of CLI during a defined period 
from a defined populat ion and therefore gives a good 
picture of the long-term socioeconomic consequences 
of CLI treatment. The treatment level was ascertained 
for all patients for their remaining lifetime or until the 
end of the study, resulting in exact information on 
every patient for a long follow-up period (5 years). 
This is different from many studies where costs have 
been calculated only for the hospital-based treatment, 
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Amputations, non-institutionalised patients 
Amputations, institutionalised patients 
Amputations, all 
Reconstructions, all 
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50 000 100 000 150 000 
Cost (FIM)/Survival year 
Fig. 3. Costs per survival year for reconstructions, amputations and their subgroups. All amputations v . all reconstructions p=0.047. 
Non-institutional amputations v . all reconstructions p<0.001. Subgroup analysis: ANOVA F = 7.6, p<0.001 (Scheffe's test). Reconstruction 
÷ amputation vs. reconstruction only p<0.05. 
and later long-term care costs have only been ap- 
proximated or not calculated at all .  2'3'7'19 This increases 
the significance of the results in the present study. The 
cost calculation was based on the figures given by the 
accountants atthe different reatment levels. As there 
was some variation in the figures given for non- 
hospital-based care, a mean value for each of these 
treatment/care levels was used, minimising possible 
distortions by single values. 
The Finnish health care system is still developing its 
methods of cost calculations for services provided by 
the society. It can therefore be assumed that there may 
be inaccuracies, e.g. in calculation of capital costs where 
8% was used as an overall figure according to in- 
formation from the management of the hospitals and 
institutions. In the cost calculation it was not possible 
to take into account costs for transportation which is 
often paid by the society for patients with limited mo- 
bility. The costs for these services could not be traced 
reliably and they have therefore been left out of the 
calculations. However, using the known transportation 
costs combined with the geographical distribution of 
patients the maximal increase in costs in the re- 
construction group would be <1.5% making the in- 
fluence on the comparison between groups insignificant. 
In our region, an aggressive reconstruction policy 
had been applied for almost 10 years before the start of 
the study. 5'11 Consequently amputation was primarily 
offered only to patients whose general condition did 
not justify reconstruction (mainly immobile, in- 
stitutionalised patients) or when a reconstruction was 
not technically feasible. 2'18 This resulted in two different 
groups of patients coming to amputation, one where 
the aim was to ease the pain and suffering of the 
patient and facilitate institutional treatment, and a 
second group where amputation had to be performed 
in a patient when a reconstruction was justified but 
could not be performed for technical reasons. The age 
and life expectancy for these two groups was also quite 
different. Randomisation of patients to amputation 
or reconstruction to compare clinical and economic 
outcome is not ethically acceptable. However, the pre- 
operatively independent primary amputation patients 
were demographically comparable to those under- 
going a reconstruction although their preoperative 
ischaemia was more severe. 
The additional procedures necessary during the fol- 
low-up period increased the costs especially in the 
reconstruction group where follow-up treatment costs 
were 1.7 times those of primary treatment, while in 
the amputation group they constituted only 20%. The 
primary reconstructive procedure should therefore be 
seen only as the first step in a continuous treatment 
commitment to keep the leg viable and the patient 
mobile. I7'2° Therefore the costs for the reconstruction 
patients are mainly follow-up treatment costs neces- 
sary to achieve long-term leg salvage. If the attempts 
to salvage a leg had to be abandoned, and a primary 
or secondary amputation performed, the need for 
additional procedures was small, and the life ex- 
pectancy of the patient short, as patients undergoing 
an amputation had a shorter survival than those with 
a salvaged leg. 
The consumption of health care resources was re- 
flected in the amount of days at the different treatment 
levels and at home. In this respect only treatment 
and care caused by CLI was regarded as relevant. 
Treatment and care for other easons were not included 
in cost calculations. For preoperatively mobile patients 
salvage of the leg was crucial for independent living. 
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Al l  pat ients  w i th  a sa lvaged leg were  able to cont inue 
their  independent  life w i th  on ly  short  stays in in- 
st i tut ional  care. Amputat ions  in this g roup  resu l ted in 
a lmost  a th i rd  of the remain ing  surv iva l  days  be ing  
spent  in hosp i ta l  or inst i tut ional  care. This is in ac- 
cordance w i th  prev ious  results.  21 
As the preoperat ive  t reatment  level  was  used  as the 
start ing po in t  and  costs ca lculated as increases or 
decreases depend ing  on the postoperat ive  t reatment  
level,  pat ients  a l ready  preoperat ive ly  in inst i tut ional  
care accrued very  low costs after an amputat ion  as 
their  stay in the hosp i ta l  for surgery  was  short,  the 
t reatment  inexpens ive  and  their  cont inued care was  
on a less expens ive  level  in some cases. For all those 
pat ients  who preoperat ive ly  ived at home or in service 
hous ing,  the t reatment  costs were  h igh  both  for a 
reconstruct ion and  an amputat ion .  For  these, the costs /  
pat ient  for amputat ions  were  somewhat  h igher  than 
for reconstruct ions.  A reconstruct ion w i thout  sub-  
sequent  amputat ion  had  the lowest  costs in in- 
dependent ly  l iv ing mobi le  pat ients  whi le  a subsequent  
amputat ion  after a reconstruct ion was  the most  ex- 
pens ive  alternat ive.  One cause for h igh  costs was  the 
f requent  occurrence of contra latera l  CLI necess i tat ing 
add i t iona l  reconstruct ions and  amputat ions .  
Compar ing  the costs for reconstruct ion and  am- 
putat ion  in re lat ion to accrued surv iva l  years  ac- 
centuates the differences. An  amputat ion  of a 
prev ious ly  mobi le  pat ient  was  about  twice as ex- 
pens ive  on a cos t /year  level  as a reconstruct ion,  in- 
c lud ing  also those fo l lowed by  an amputat ion .  For a 
h igh  propor t ion  of mobi le  pat ients  w i th  CLI, a p r imary  
or secondary  amputat ion  leads to inst i tut ional  long-  
term care w i th  h igh  costs. These costs for long- term 
care outwe igh  the costs for a vascu lar  reconstruct ion 
and  its fo l low-up treatment.  Based on these f ind ings 
there is no economic  reason to per fo rm an amputat ion  
in preference to a reconstruct ion in independent ly  
l iv ing pat ients.  For these pat ients,  p reserved  mobi l i ty  
and  the qual i ty  of life shou ld  be the main  factors in 
dec id ing  on leg sa lvage at tempts  through a re- 
construct ion.  14 For the immobi le  pat ient  a l ready  in 
inst i tut ional  care where  CLI const i tutes a care prob lem,  
an amputat ion  is often an inevi table and  inexpens ive  
solut ion.  
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